Consistent with these findings, the ex vivo gene therapy by LV-hTRIM31 further demonstrated that mice transplanted with human TRIM31 RINGΔ-hepatocytes transplantation also did not markedly alleviate HFD-induced insulin resistance, liver steatosis, and inflammation (Supplementary Fig. S13a–g). The gene discussed is TRIM31; the disease is Insulin resistance.